Harvard Bioscience (HBIO) Receivables - Other (2010 - 2019)
Harvard Bioscience (HBIO) posted quarterly Receivables - Other of $386000.0 for Q2 2019, up 1778.26% year-over-year from $20550.9 in Q2 2018, and up 172.01% quarter-over-quarter from -$536000.0 in Q1 2019.
Harvard Bioscience (HBIO) Receivables - Other (2010 - 2019) Analysis & Trends
Harvard Bioscience (HBIO) has reported Receivables - Other for 10 consecutive years, with $386000.0 the latest figure, recorded in Q2 2019.
- In Q2 2019, Receivables - Other rose 1778.26% year-over-year to $386000.0; the TTM figure through Jun 2019 stood at $647000.0 (up 164.64% YoY), while the FY2018 annual figure was $124000.0, up 21.57% from the prior year.
- Receivables - Other rose to $386000.0 in Q2 2019 per HBIO's latest filing, from -$536000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $1.9 million in Q3 2018 and bottomed at -$1.2 million in Q4 2015.
- Historically, Receivables - Other has averaged -$1166.7 across 5 years, with a median of $34000.0 in 2015.
- On a YoY basis, Receivables - Other climbed as much as 3080.0% in 2015 and fell as far as 1110.42% in 2015.
- Harvard Bioscience's Receivables - Other stood at -$1.2 million in 2015, then soared by 92.77% to -$84000.0 in 2016, then tumbled by 448.81% to -$461000.0 in 2017, then slumped by 129.93% to -$1.1 million in 2018, then jumped by 136.42% to $386000.0 in 2019.
- Business Quant data shows HBIO's Receivables - Other at $386000.0 in Q2 2019, -$536000.0 in Q1 2019, and -$1.1 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.60 Bn | 129.38 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.75 Bn | 51.89 Bn | 2.32 Bn |
| 3 | Alcon | 35.82 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.75 Bn | 32.28 Bn | 861.22 Mn |
| 5 | Medline | 29.37 Bn | 26.69 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn |
| 7 | Solventum | 15.44 Bn | 15.04 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.87 Bn | 14.73 Bn | 735.40 Mn |
| 9 | Baxter International | 13.54 Bn | 11.39 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.90 Mn | 27.39 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 386,000.00 |
| Jun 30, 2019 | 386,000.00 |
| Mar 31, 2019 | -536,000.00 |
| Mar 31, 2019 | -536,000.00 |
| Dec 31, 2018 | -1.06 Mn |
| Dec 31, 2018 | -1.06 Mn |
| Sep 30, 2018 | 1.86 Mn |
| Sep 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | -23,000.00 |
| Jun 30, 2018 | -23,000.00 |
| Mar 31, 2018 | -650,000.00 |
| Mar 31, 2018 | -650,000.00 |
| Dec 31, 2017 | -461,000.00 |
| Dec 31, 2017 | -461,000.00 |
| Sep 30, 2017 | 133,000.00 |
| Sep 30, 2017 | 133,000.00 |
| Jun 30, 2017 | -96,000.00 |
| Jun 30, 2017 | -96,000.00 |
| Mar 31, 2017 | 526,000.00 |
| Mar 31, 2017 | 526,000.00 |